| Literature DB >> 29407729 |
Yixing Du1, Wei Wang2, Anthony D Lutton3, Conrad M Kiyoshi1, Baofeng Ma1, Anne T Taylor1, John W Olesik3, Dana M McTigue1, Candice C Askwith1, Min Zhou4.
Abstract
Membrane potential (VM) depolarization occurs immediately following cerebral ischemia and is devastating for the astrocyte homeostasis and neuronal signaling. Previously, an excessive release of extracellular K+ and glutamate has been shown to underlie an ischemia-induced VM depolarization. Ischemic insults should impair membrane ion channels and disrupt the physiological ion gradients. However, their respective contribution to ischemia-induced neuronal and glial depolarization and loss of neuronal excitability are unanswered questions. A short-term oxygen-glucose deprivation (OGD) was used for the purpose of examining the acute effect of ischemic conditions on ion channel activity and physiological K+ gradient in neurons and glial cells. We show that a 30 min OGD treatment exerted no measurable damage to the function of membrane ion channels in neurons, astrocytes, and NG2 glia. As a result of the resilience of membrane ion channels, neuronal spikes last twice as long as our previously reported 15 min time window. In the electrophysiological analysis, a 30 min OGD-induced dissipation of transmembrane K+ gradient contributed differently in brain cell depolarization: severe in astrocytes and neurons, and undetectable in NG2 glia. The discrete cellular responses to OGD corresponded to a total loss of 69% of the intracellular K+ contents in hippocampal slices as measured by Inductively Coupled Plasma Mass Spectrometry (ICP-MS). A major brain cell depolarization mechanism identified here is important for our understanding of cerebral ischemia pathology. Additionally, further understanding of the resilient response of NG2 glia to ischemia-induced intracellular K+ loss and depolarization should facilitate the development of future stroke therapy.Entities:
Keywords: Astrocytes; Brain ischemia; Ion channel; NG2 glia; Neurons
Mesh:
Substances:
Year: 2018 PMID: 29407729 PMCID: PMC5864540 DOI: 10.1016/j.expneurol.2018.01.019
Source DB: PubMed Journal: Exp Neurol ISSN: 0014-4886 Impact factor: 5.330